Methods for reducing CD36 expression
US7811987B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | May 1, 2009 |
| Grant date | Oct 12, 2010 |
| Priority date | — |
| Expiry date | May 1, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a method for reducing CD36 expression in a cell. The method comprises contacting the cell with an effective amount of an aromatic-cationic peptide having at least one net positive charge; a minimum of four amino acids; a maximum of about twenty amino acids; a relationship between the minimum number of net positive charges (pm) and the total number of amino acid residues (r) wherein 3 pm is the largest number that is less than or equal to r+1; and a relationship between the minimum number of aromatic groups (a) and the total number of net positive charges (pt) wherein 2a is the largest number that is less than or equal to pt+1, except that when a is 1, pt may also be 1.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.